
Videos




Managing Metastatic Hepatocellular Carcinoma

Fabrice André, MD, PhD, professor in the Department of Medical Oncology at the Institut Gustave Roussy in Villejuif, France, addresses questions regarding the use of platinum regimens for patients with triple-negative breast cancer (TNBC). He discusses 2 platinum agents, cisplatin and carboplatin, and when it is recommended that these agents be used.

Selina Chen-Kiang, PhD, a professor of pathology and immunology at Weill Cornell Medical College, discusses the rationale of her phase I trial investigating the use of CDK4/6 inhibitors for the treatment of patients with mantle cell lymphoma.








Managing High-Risk Multiple Myeloma







Therapeutic Approach for Metastatic Renal Cell Carcinoma








Intermediate-Risk Newly Diagnosed Metastatic Renal Cell Carcinoma

Scott Newman, PhD, St. Jude Children’s Research Hospital, discusses the St. Jude Cloud data-sharing resource for the research community.


